These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Anti-inflammatory and antinociceptive effects of Chinese medicine SQ gout capsules and its modulation of pro-inflammatory cytokines focusing on gout arthritis. Kodithuwakku ND; Pan M; Zhu YL; Zhang YY; Feng YD; Fang WR; Li YM J Ethnopharmacol; 2013 Dec; 150(3):1071-9. PubMed ID: 24161431 [TBL] [Abstract][Full Text] [Related]
28. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. Borstad GC; Bryant LR; Abel MP; Scroggie DA; Harris MD; Alloway JA J Rheumatol; 2004 Dec; 31(12):2429-32. PubMed ID: 15570646 [TBL] [Abstract][Full Text] [Related]
29. [Why anti-gout agents when patients with gouty arthritis are to be surgically treated]. Hørslev-Petersen K Ugeskr Laeger; 1998 Apr; 160(15):2233. PubMed ID: 9599516 [No Abstract] [Full Text] [Related]
30. The Unique Macroscopic Appearance of Gouty Arthritis of the Knee. Mittl GS; Zuckerman JD Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):210-2. PubMed ID: 26535601 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of arthritis urica and hyperuricemia]. Høieggen A Tidsskr Nor Laegeforen; 1992 Mar; 112(8):1038-40. PubMed ID: 1553729 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study. Yazici Y; Curtis JR; Ince A; Baraf H; Malamet RL; Teng LL; Kavanaugh A Ann Rheum Dis; 2012 Feb; 71(2):198-205. PubMed ID: 21949007 [TBL] [Abstract][Full Text] [Related]
33. [Treatment for gouty arthritis]. Shimizu T Nihon Rinsho; 1996 Dec; 54(12):3267-71. PubMed ID: 8976103 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of anakinra for various types of crystal-induced arthritis in complex hospitalized patients: a case series and review of the literature. Aouba A; Deshayes S; Frenzel L; Decottignies A; Pressiat C; Bienvenu B; Boue F; Damaj G; Hermine O; Georgin-Lavialle S Mediators Inflamm; 2015; 2015():792173. PubMed ID: 25922564 [TBL] [Abstract][Full Text] [Related]
35. Gout and hyperuricemia. Harris MD; Siegel LB; Alloway JA Am Fam Physician; 1999 Feb; 59(4):925-34. PubMed ID: 10068714 [TBL] [Abstract][Full Text] [Related]
36. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis. Inaba Y; Ozawa R; Aoki C; Imagawa T; Mori M; Hara R; Miyamae T; Saito T; Yokota S Mod Rheumatol; 2013 Jul; 23(4):667-73. PubMed ID: 22791270 [TBL] [Abstract][Full Text] [Related]
37. [Current opinions on gout, its diagnosis and treatment]. Němec P Vnitr Lek; 2012 Dec; 58(12):928-37. PubMed ID: 23427951 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat. Huang J; Zhu M; Tao Y; Wang S; Chen J; Sun W; Li S J Pharm Pharmacol; 2012 Aug; 64(8):1119-27. PubMed ID: 22775215 [TBL] [Abstract][Full Text] [Related]
39. Successful use of tocilizumab in a patient with psoriatic arthritis. Hughes M; Chinoy H Rheumatology (Oxford); 2013 Sep; 52(9):1728-9. PubMed ID: 23424264 [No Abstract] [Full Text] [Related]
40. Should patients with interval gout be treated with urate lowering drugs? Fam AG J Rheumatol; 1995 Sep; 22(9):1621-3. PubMed ID: 8523333 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]